首页> 外国专利> - Composition for preventing or treating ischemic cardiac diseases comprising inhibiting agent for synthesis or secretion of AGE-albumin of mononuclear phagocyte as active ingredient

- Composition for preventing or treating ischemic cardiac diseases comprising inhibiting agent for synthesis or secretion of AGE-albumin of mononuclear phagocyte as active ingredient

机译:-用于预防或治疗缺血性心脏病的组合物,其包含用于合成或分泌单核吞噬细胞的AGE-白蛋白的抑制剂作为活性成分。

摘要

The present invention relates to a pharmaceutical composition for the prevention or treatment of ischemic heart disease, which comprises, as an active ingredient, an inhibitor which inhibits the synthesis or secretion of AGE-albumin of mononuclear cells that induce cell death of myocardial cells at the onset of ischemic heart disease, To a screening method. The pharmaceutical composition for the prevention or treatment of ischemic heart disease of the present invention can inhibit or reduce the cell death induced by AGE-albumin by including the synthesis or secretion inhibitor of AGE-albumin of mononuclear cells as an active ingredient, And may be widely used for the prevention or treatment of various ischemic heart diseases.
机译:本发明涉及用于预防或治疗缺血性心脏病的药物组合物,其包含作为活性成分的抑制剂,该抑制剂抑制诱导单核细胞在心肌细胞死亡的单核细胞的AGE-白蛋白的合成或分泌。缺血性心脏病的发作,要有筛查方法。本发明的用于预防或治疗缺血性心脏病的药物组合物可以通过包含单核细胞的AGE-白蛋白的合成或分泌抑制剂作为有效成分来抑制或减少由AGE-白蛋白引起的细胞死亡,并且可以是广泛用于预防或治疗各种缺血性心脏病。

著录项

  • 公开/公告号KR101939401B1

    专利类型

  • 公开/公告日2019-01-16

    原文格式PDF

  • 申请/专利权人 가천대학교 산학협력단;

    申请/专利号KR20110116914

  • 发明设计人 이봉희;변경희;

    申请日2011-11-10

  • 分类号A61K39/395;A61K38/38;A61P9;A61P9/10;

  • 国家 KR

  • 入库时间 2022-08-21 11:49:20

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号